#	Pagina
attuale pagina	/open-h2020/projects/221559/index.html
-1	/open-h2020/per-topic/steered/list/index.html

Opendata, web and dolomites

Oncogenic PI3-kinase SIGNED

New biology of oncogenic PI 3-kinase

Total Cost €

EC-Contrib. €

Partnership

Views

Oncogenic PI3-kinase project word cloud

Explore the words cloud of the Oncogenic PI3-kinase project. It provides you a very rough idea of what is the project "Oncogenic PI3-kinase" about.

activated innovative pharmacological progression suppressor functions signalling hypoxia host mechanism probing view representative unbiased death promotor tumour molecule biology starvation oncogenic cell pi solid kinase endogenous modulators genetic multiple incomplete tissue tumours central scientific activating predominantly pi3k therapies experimental pik3ca mechanisms biased ed premise hypoxic merge mainly world pten formulated mice genetically alpha breakthroughs gene mutant lab frequently mutations starved regulates career settings class small subunit unappreciated previously heterozygous nutrient kill assertion expertise biological cells understand respectively inactivation contexts encoding uncover cancer opposes catalytic drug activation sustained oxygen

Project "Oncogenic PI3-kinase" data sheet

The following table provides information about the project.

Coordinator	UNIVERSITY COLLEGE LONDON Organization address address: GOWER STREET city: LONDON postcode: WC1E 6BT website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	United Kingdom [UK]
Total cost	212˙933 €
EC max contribution	212˙933 € (100%)
Programme	1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
Code Call	H2020-MSCA-IF-2018
Funding Scheme	MSCA-IF-EF-ST
Starting year	2019
Duration (year-month-day)	from 2019-05-01 to 2021-04-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	UNIVERSITY COLLEGE LONDON UNIVERSITY COLLEGE LONDON Organization address address: GOWER STREET city: LONDON postcode: WC1E 6BT website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (LONDON)	coordinator	212˙933.00

Map

Project objective

PI 3-kinase (PI3K) signalling regulates multiple cell functions and is one of the most frequently genetically-activated pathways in cancer. This is mainly due to activating mutations in PIK3CA (the gene encoding the PI3Kα catalytic subunit) or inactivation of the tumour-suppressor PTEN (which opposes PI3K signalling).

Solid tumours are most often hypoxic and nutrient-starved. The central premise of my proposal is that PI3K signalling has thus far been predominantly investigated under experimental settings not representative of these cancer-relevant tissue contexts. In our view, this has resulted in an incomplete understanding of PI3K biology in cancer. Based on this assertion, I have formulated two key objectives: (1) To uncover previously-unappreciated signalling mechanisms of oncogenic PIK3CA under cancer-relevant conditions of long-term starvation and/or hypoxia. (2) To understand the mechanism of cell death induced by an innovative, new type of PI3K modulators, generated by the Host Lab, that kill PIK3CA-mutant cancer cells under hypoxic conditions.

These objectives will be achieved by, respectively: (1) Biased and unbiased genetic and pharmacological approaches in cells and mice, including probing signalling under conditions of (A) nutrient and/or oxygen starvation (B) sustained low-level signalling due to genetic PIK3CA activation in the heterozygous state and from the endogenous promotor, as is the case in cancer. (2) Using unique small-molecule PI3K pathway modulators developed in the Host Lab, in cell-biological and signalling studies.

These objectives will merge my expertise in signalling under nutrient-starved conditions with world-class know-how in PI3K cancer studies and drug development in the Host Lab. This proposal aims to make scientific breakthroughs in understanding cancer-related PI3K signalling, promoting the progression of my career and allowing the Host Lab to achieve its key long-term aim to make PI3K-based cancer therapies work.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ONCOGENIC PI3-KINASE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ONCOGENIC PI3-KINASE" are provided by the European Opendata Portal: CORDIS opendata.